How much ciprofloxacin (fluoroquinolone antibiotic) is present in breast milk 4 hours after administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ciprofloxacin Concentration in Breast Milk at 4 Hours Post-Dose

At 4 hours after taking ciprofloxacin, breast milk concentrations are at their lowest point (approximately 2.26-3.79 mcg/mL), making this the optimal time for breastfeeding to minimize infant exposure. 1, 2

Specific Concentration Data

The most direct evidence comes from a pharmacokinetic study in lactating women who received 750 mg oral ciprofloxacin:

  • At 4 hours post-dose: mean breast milk level was 2.26 mcg/mL 2
  • At 2 hours: 3.79 mcg/mL (peak concentration) 2
  • At 6 hours: 0.86 mcg/mL 2
  • At 9 hours: 0.51 mcg/mL 2

A separate case report of a single 500 mg oral dose found:

  • At 4 hours: 9.1 mcmol/L (approximately 3.0 mcg/mL) 3
  • Concentrations remained stable at 9.1 mcmol/L through 8 and 12 hours 3

Clinical Significance of These Levels

These breast milk concentrations are two orders of magnitude (100-fold) lower than typical therapeutic infant doses, making the exposure clinically insignificant 1, 4, 5:

  • The infant receives far less drug through breast milk than would be given for direct treatment 1
  • Calcium in breast milk further reduces absorption of ciprofloxacin in the infant's gastrointestinal tract 1, 4, 5

Practical Timing Recommendation

To minimize infant exposure further, breastfeeding should be timed to occur 3-4 hours after each maternal ciprofloxacin dose, when drug concentrations in breast milk reach their nadir 1, 4, 5. This timing strategy reduces theoretical risks while allowing continued breastfeeding 1.

Important Caveats

While these concentrations are measurable, the actual risk to breastfed infants remains theoretical:

  • Despite animal studies showing cartilage concerns, human data during breastfeeding show low risk 4, 5
  • No cases of arthropathy have been documented in breastfed infants exposed to ciprofloxacin 4
  • Potential minor effects include altered intestinal flora or false-negative cultures if the infant becomes febrile 4, 5

If ciprofloxacin is medically necessary for the mother, breastfeeding can continue with strategic timing around the 3-4 hour mark post-dose 1, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ciprofloxacin penetration into human breast milk: a case report.

DICP : the annals of pharmacotherapy, 1990

Guideline

Ciprofloxacin Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ciprofloxacin Use During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.